Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Expert Rev Mol Diagn ; 17(12): 1117-1125, 2017 12.
Article in English | MEDLINE | ID: mdl-28965426

ABSTRACT

BACKGROUND: A variety of sample preparation techniques are used prior to nucleic acid amplification. However, their efficiency is not always sufficient and nucleic acid purification remains the preferred method for template preparation. Purification is difficult and costly to apply in point-of-care (POC) settings and there is a strong need for more robust, rapid, and efficient biological sample preparation techniques in molecular diagnostics. METHODS: Here, the authors applied antimicrobial peptides (AMPs) for urine sample preparation prior to isothermal loop-mediated amplification (LAMP). AMPs bind to many microorganisms such as bacteria, fungi, protozoa and viruses causing disruption of their membrane integrity and facilitate nucleic acid release. RESULTS: The authors show that incubation of E. coli with antimicrobial peptide cecropin P1 for 5 min had a significant effect on the availability of template DNA compared with untreated or even heat treated samples resulting in up to six times increase of the amplification efficiency. CONCLUSION: These results show that AMPs treatment is a very efficient sample preparation technique that is suitable for application prior to nucleic acid amplification directly within biological samples. Furthermore, the entire process of AMPs treatment was performed at room temperature for 5 min thereby making it a good candidate for use in POC applications.


Subject(s)
Anti-Infective Agents/pharmacology , Pathology, Molecular , Peptides/pharmacology , Point-of-Care Systems , Escherichia coli/drug effects , Escherichia coli/genetics , Escherichia coli/pathogenicity , Humans , Nucleic Acid Amplification Techniques , Peptides/genetics , Specimen Handling
2.
Expert Rev Mol Diagn ; 17(4): 403-410, 2017 04.
Article in English | MEDLINE | ID: mdl-28092481

ABSTRACT

BACKGROUND: The use of rapid amplification methods to detect pathogens in biological samples is mainly limited by the amount of pathogens present in the sample and the presence of inhibiting substances. Inhibitors can affect the amplification efficiency by either binding to the polymerase, interacting with the DNA, or interacting with the polymerase during primer extension. Amplification is performed using DNA polymerase enzymes and even small changes in their activity can influence the sensitivity and robustness of molecular assays Methods: The main purpose of this research was to examine which compounds present in urine inhibit polymerases with strand displacement activity. To quantify the inhibition, we employed quantitative loop-mediated isothermal amplification Results: The authors found that the presence of BSA, Mg 2+, and urea at physiologically relevant concentrations, as well as acidic or alkaline conditions did not affect the activity of any of the tested polymerases. However, addition of salt significantly affected the activity of the tested polymerases. CONCLUSION: These findings may aid in the development of more sensitive, robust, cost effective isothermal amplification based molecular assays suitable for both point-of-care testing and on-site screening of pathogens directly from unprocessed urine which avoid the need for long and tedious DNA purification steps prior to amplification.


Subject(s)
Chlamydia Infections/genetics , Chlamydia Infections/urine , Chlamydia trachomatis/genetics , Enzyme Inhibitors/urine , Self-Sustained Sequence Replication/methods , Urine/microbiology , Female , Humans , Male
3.
BMC Infect Dis ; 16: 329, 2016 07 13.
Article in English | MEDLINE | ID: mdl-27412444

ABSTRACT

BACKGROUND: Chlamydia trachomatis is an obligate intracellular human pathogen and is the most common cause of sexually transmitted diseases affecting both men and women. The pathogen can cause prostatitis and epididymitis in men. In women, cervicitis, pelvic inflammatory disease, ectopic pregnancy and acute or chronic pelvic pain are frequent complications. More than half of C. trachomatis-positive patients have minimal or no symptoms, providing an ongoing reservoir for the infection. The lack of sensitive large-scale applicable point- of- care (POC) tests for C. trachomatis detection makes it difficult to diagnose chlamydia infection efficiently in resource-limited environments. METHODS: A rapid and sensitive assay based on loop-mediated isothermal amplification method (LAMP) was combined with antimicrobial peptide lysis, which is able to detect at least 7 C. trachomatis pathogens per reaction directly from urine samples. RESULTS: Our study comprising 91 first-void urine samples showed that specificity of the assay is 100 % and sensitivity 73 % when using antimicrobial peptide lysis mix. Additionally we demonstrate that our assay does not give any cross-reactivity with 30 pathogen's DNA potentially present in the urine samples. Furthermore, the assay's novel approach does not require purification or extraction of DNA from clinical sample prior to amplification, so the need for specialized equipment is eliminated. CONCLUSIONS: The whole procedure is significantly less laborious, less time-consuming and consequently less expensive for early detection and identification of infectious disease. C. trachomatis specific LAMP assay is relatively simple to perform and could therefore be applied in numerous POC settings.


Subject(s)
Anti-Infective Agents/pharmacology , Antimicrobial Cationic Peptides/pharmacology , Chlamydia Infections/diagnosis , Chlamydia trachomatis/genetics , DNA, Bacterial/urine , Nucleic Acid Amplification Techniques/methods , Chlamydia trachomatis/drug effects , Chlamydia trachomatis/isolation & purification , DNA, Bacterial/isolation & purification , DNA, Bacterial/metabolism , Female , Humans , Limit of Detection , Male , Point-of-Care Systems , Pregnancy , Sensitivity and Specificity
4.
J Mol Diagn ; 16(1): 127-35, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24331366

ABSTRACT

Chlamydia trachomatis is the most common sexually transmitted human pathogen. Infection results in minimal to no symptoms in approximately two-thirds of women and therefore often goes undiagnosed. C. trachomatis infections are a major public health concern because of the potential severe long-term consequences, including an increased risk of ectopic pregnancy, chronic pelvic pain, and infertility. To date, several point-of-care tests have been developed for C. trachomatis diagnostics. Although many of them are fast and specific, they lack the required sensitivity for large-scale application. We describe a rapid and sensitive form of detection directly from urine samples. The assay uses recombinase polymerase amplification and has a minimum detection limit of 5 to 12 pathogens per test. Furthermore, it enables detection within 20 minutes directly from urine samples without DNA purification before the amplification reaction. Initial analysis of the assay from clinical patient samples had a specificity of 100% (95% CI, 92%-100%) and a sensitivity of 83% (95% CI, 51%-97%). The whole procedure is fairly simple and does not require specific machinery, making it potentially applicable in point-of-care settings.


Subject(s)
Chlamydia Infections/diagnosis , Chlamydia Infections/urine , Chlamydia trachomatis/genetics , Sexually Transmitted Diseases, Bacterial/diagnosis , Sexually Transmitted Diseases, Bacterial/urine , Chlamydia Infections/genetics , Chlamydia trachomatis/enzymology , DNA, Bacterial/analysis , DNA-Directed DNA Polymerase/chemistry , Diacylglycerol Cholinephosphotransferase/genetics , Female , Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating)/genetics , Humans , Molecular Diagnostic Techniques/methods , Nucleic Acid Amplification Techniques , Polymerase Chain Reaction , Recombinases/chemistry , Sensitivity and Specificity , Sexually Transmitted Diseases, Bacterial/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...